TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33008455

Group type: EXPERIMENTAL
Intervention: Practice Facilitation (PF) as a quality improvement strategy for implementing TASSH
Number of subjects: 700
Study: 35409571

Group type: EXPERIMENTAL
Intervention: Athletics
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Handball
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study: 34491840

Group type: EXPERIMENTAL
Intervention: 0.01% atropine administered one day before exposure to hyperopic blur
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo/hyperopic (-3 D) blur
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo/no blur
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo/hyperopic blur one day after administration of 0.01% atropine
Number of subjects: 20
Study: 32790725

Group type: EXPERIMENTAL
Intervention: Wawamum (50 grams/day)
Number of subjects: 870

Group type: COMPARATOR
Intervention: Standard government health services
Number of subjects: 870
Study: 34999333

Group type: EXPERIMENTAL
Intervention: Carbohydrate counting
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Carbohydrate counting combined with DASH
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 75
Study: 33385439

Group type: EXPERIMENTAL
Intervention: Ketamine (subanesthetic dose)
Number of subjects: 21
Study: 35871319

Group type: EXPERIMENTAL
Intervention: Cross trainer exercise starting 3 days postoperatively
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 50
Study: 33404997

Group type: EXPERIMENTAL
Intervention: Wearable cardioverter defibrillators (WCD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Subcutaneous implantable cardioverter defibrillators (S-ICDs)
Number of subjects: 0
Study: 33460198

Group type: EXPERIMENTAL
Intervention: Gabapentin Enacarbil Extended-Release (GE-XR) 600 mg twice-a-day
Number of subjects: 338

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 338
Study: 33586615

Group type: EXPERIMENTAL
Intervention: Heat stress (HS)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Non-heat-stressed condition (NC)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: RNA sequencing and qRT-PCR
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: GO annotation and KEGG analysis
Number of subjects: 2
Study: 34562391

Group type: EXPERIMENTAL
Intervention: Amoxicillin 50 mg/kg per day for 7 days
Number of subjects: 432

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 432
Study: 32682735

Group type: EXPERIMENTAL
Intervention: Informative video about mandibular third molar removal
Number of subjects: 47

Group type: COMPARATOR
Intervention: No informative video (control group)
Number of subjects: 47
Study: 33413034

Group type: EXPERIMENTAL
Intervention: Training group (TG) - 15 weeks of combined aerobic exercise and strength training, 90-min supervised sessions weekly, encouraged home-based training 30 min/week
Number of subjects: 45

Group type: COMPARATOR
Intervention: Inactive control group (CG)
Number of subjects: 45
Study: 33866269

Group type: EXPERIMENTAL
Intervention: Computed Tomography (CT) imaging
Number of subjects: 174

Group type: COMPARATOR
Intervention: Ultrasound (US) imaging
Number of subjects: 174
Study: 35263425

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 36

Group type: COMPARATOR
Intervention: Dapagliflozin
Number of subjects: 36

Group type: COMPARATOR
Intervention: Acarbose
Number of subjects: 36
Study: 33158945

Group type: EXPERIMENTAL
Intervention: Standard limb RYGB (50‐cm biliopancreatic limb)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Long limb RYGB (150‐cm biliopancreatic limb)
Number of subjects: 53
Study: 32579859

Group type: EXPERIMENTAL
Intervention: Telepractice voice therapy
Number of subjects: 69

Group type: COMPARATOR
Intervention: Conventional voice therapy
Number of subjects: 69
Study: 35584484

Group type: EXPERIMENTAL
Intervention: Seating system + exercise (SSE-group; n=15)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Exercise (E-group; n=14)
Number of subjects: 29
Study: 34271952

Group type: EXPERIMENTAL
Intervention: Usual care supplemented by five group-based cognitive therapy sessions performed by trained CR nurses
Number of subjects: 148

Group type: COMPARATOR
Intervention: Usual out-patient cardiac rehabilitation (CR) comprising an 8-week multidisciplinary programme
Number of subjects: 148
Study: 34086521

Group type: EXPERIMENTAL
Intervention: Peer-befriending intervention
Number of subjects: 28
Study: 32991508

Group type: EXPERIMENTAL
Intervention: Pilates exercises (12-week program)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Control group (n = 54)
Number of subjects: 109
Study: 34243938

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 90

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 90
Study: 35779016

Group type: EXPERIMENTAL
Intervention: Fracture Liaison Service (FLS) pathway for osteoporosis management
Number of subjects: 491
Study: 32162045

Group type: EXPERIMENTAL
Intervention: Repair with additional internal bracing using two anchors (group II)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Repair using one humeral anchor (group III)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Repair alone (group I)
Number of subjects: 21
Study: 35550508

Group type: EXPERIMENTAL
Intervention: 1-year low-dose metronomic methotrexate-based chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: No maintenance chemotherapy
Number of subjects: 0
Study: 34895435

Group type: EXPERIMENTAL
Intervention: Christmas hats
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Reindeer antlers
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Small black bars
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Large black bars
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: T-shapes
Number of subjects: 33

Group type: COMPARATOR
Intervention: Unmodified photos
Number of subjects: 33
Study: 35749510

Group type: EXPERIMENTAL
Intervention: Financial incentives for ART adherence
Number of subjects: 49
Study: 33952397

Group type: EXPERIMENTAL
Intervention: Intensive glucose control
Number of subjects: 9405

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 9405
Study: 32487180

Group type: EXPERIMENTAL
Intervention: Family Club Denmark intervention group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 0
Study: 35043012

Group type: EXPERIMENTAL
Intervention: Suction drainage
Number of subjects: 40

Group type: COMPARATOR
Intervention: No suction drainage (control)
Number of subjects: 40
Study: 33953794

Group type: EXPERIMENTAL
Intervention: TAP positive expression before radiotherapy
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: TAP levels post-radiotherapy
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: SCC and CEA levels
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Chest CT examination for short-term efficacy evaluation
Number of subjects: 95
Study: 33121536

Group type: EXPERIMENTAL
Intervention: Multilevel intervention including provider and staff education, provider reminder, provider assessment and feedback, patient reminder, and patient navigation.
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control group (no intervention components implemented during the 3-month waiting period).
Number of subjects: 4
Study: 35931957

Group type: EXPERIMENTAL
Intervention: Single plasma exchange
Number of subjects: 5

Group type: COMPARATOR
Intervention: Double filtration plasmapheresis (DFPP)
Number of subjects: 5
Study: 34793890

Group type: EXPERIMENTAL
Intervention: WebQuest educational strategy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 100
Study: 34519620

Group type: EXPERIMENTAL
Intervention: fSKEPT with conflict-related treatment focus
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: fSKEPT with personality functioning-specific interventions
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: fSKEPT with unspecific interventions
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: fSKEPT with conflict focus
Number of subjects: 81
Study: 32859477

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ)
Number of subjects: 3451

Group type: COMPARATOR
Intervention: No Hydroxychloroquine (Control)
Number of subjects: 3451
Study: 35897358

Group type: EXPERIMENTAL
Intervention: LLLT (Low-Level Laser Therapy)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Standard Conservative Treatment
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Combination of LLLT and Standard Conservative Treatment
Number of subjects: 32

Group type: COMPARATOR
Intervention: LLLT
Number of subjects: 32
Study: 33497850

Group type: EXPERIMENTAL
Intervention: Cogmed Working Memory Training (CWMT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 30
Study: 33143361

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chromotherapy room
Number of subjects: 0
Study: 35119537

Group type: EXPERIMENTAL
Intervention: Peer Navigation (PN) intervention
Number of subjects: 113

Group type: COMPARATOR
Intervention: Control (trans-friendly HIV care)
Number of subjects: 113
Study: 33947376

Group type: EXPERIMENTAL
Intervention: BIO Mesh Closure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Glued Closure
Number of subjects: 0
Study: 34734361

Group type: EXPERIMENTAL
Intervention: Exploring Together (ET)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Exploring Together-Adapted (ET-Adapted)
Number of subjects: 136
Study: 33998290

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 0
Study: 32090764

Group type: EXPERIMENTAL
Intervention: Moderate adherence to Traditional Mediterranean Dietary Pattern (MDP)
Number of subjects: 545

Group type: EXPERIMENTAL
Intervention: High adherence to Traditional Mediterranean Dietary Pattern (MDP)
Number of subjects: 545

Group type: COMPARATOR
Intervention: Brazilian Mediterranean Dietary Pattern (MDP)
Number of subjects: 545
Study: 36421357

Group type: EXPERIMENTAL
Intervention: DCG emotional support
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: DCG self-efficacy
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Patient anxiety
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Patient depression
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Overall burden in DCGs
Number of subjects: 314
Study: 33556350

Group type: EXPERIMENTAL
Intervention: Dry needling (DN) combined with eccentric exercise (EE)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Percutaneous needle electrolysis (PNE) combined with eccentric exercise (EE)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Eccentric exercise (EE) with sham needle (control group)
Number of subjects: 48
Study: 33198147

Group type: EXPERIMENTAL
Intervention: Brief relaxation practice
Number of subjects: 31

Group type: COMPARATOR
Intervention: Viewing greenery images
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control task
Number of subjects: 31
Study: 35653355

Group type: EXPERIMENTAL
Intervention: Stable supportive shoes
Number of subjects: 28

Group type: COMPARATOR
Intervention: Flat flexible shoes
Number of subjects: 28
Study: 35298285

Group type: EXPERIMENTAL
Intervention: Fayton Q‐switched 1064 nm Nd:YAG laser with a spot diameter of 9 mm and an energy density of 0.8 J/cm2
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Fayton Q‐switched 1064 nm Nd:YAG laser with a spot diameter of 6 mm and an energy density of 1.2 J/cm2
Number of subjects: 30
Study: 32578032

Group type: EXPERIMENTAL
Intervention: Intracytoplasmic sperm injection (ICSI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of IVF and ICSI on sibling oocytes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ICSI
Number of subjects: 0
Study: 33662301

Group type: EXPERIMENTAL
Intervention: FLACSg (600 μm grid)
Number of subjects: 93

Group type: COMPARATOR
Intervention: PE (phacoemulsification)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: FLACS16 (16-segment fragmentation)
Number of subjects: 93
Study: 32406383

Group type: EXPERIMENTAL
Intervention: Video game intervention during intravenous cannulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no video game intervention)
Number of subjects: 0
Study: 34292258

Group type: EXPERIMENTAL
Intervention: StandingTall, a home-based fall prevention program delivered through a tablet computer
Number of subjects: 50
Study: 33340731

Group type: EXPERIMENTAL
Intervention: 1470-nm laser with bare fiber (BF)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: 1470-nm laser with radial fiber (RF)
Number of subjects: 86
Study: 32554833

Group type: EXPERIMENTAL
Intervention: Yoga group
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 14
Study: 36476809

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided out-of-plane cannulation of the internal jugular vein (IJV)
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided in-plane infraclavicular cannulation of the axillary vein (AXV)
Number of subjects: 610
Study: 32926247

Group type: EXPERIMENTAL
Intervention: IV golimumab 2 mg/kg at weeks 0, 4, then every 8 weeks through week 52
Number of subjects: 208

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: IV golimumab 2 mg/kg
Number of subjects: 208

Group type: COMPARATOR
Intervention: Placebo-crossover to IV golimumab
Number of subjects: 208
Study: 32810697

Group type: EXPERIMENTAL
Intervention: Soft-soled sneakers
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Soft-soled boots
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Soft-soled sandals
Number of subjects: 47

Group type: COMPARATOR
Intervention: Barefoot
Number of subjects: 47
Study: 35122457

Group type: EXPERIMENTAL
Intervention: Obesity prevention interventions
Number of subjects: 161
Study: 34129204

Group type: EXPERIMENTAL
Intervention: BiPAP
Number of subjects: 284

Group type: COMPARATOR
Intervention: CPAP
Number of subjects: 284
Study: 33289845

Group type: EXPERIMENTAL
Intervention: DCE-MRI radiomic signature
Number of subjects: 1214

Group type: EXPERIMENTAL
Intervention: Clinical-radiomic nomogram
Number of subjects: 1214
Study: 34637495

Group type: EXPERIMENTAL
Intervention: mySmartCheck (automated internet-based intervention)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 116
Study: 34878013

Group type: EXPERIMENTAL
Intervention: Educational workshops about bonding with the fetus
Number of subjects: 19

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 19
Study: 33989966

Group type: EXPERIMENTAL
Intervention: Texture analysis (TA)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Qualitative ratings by radiologists
Number of subjects: 90
Study: 36201208

Group type: EXPERIMENTAL
Intervention: Attendance at a high-performing public charter high school
Number of subjects: 1270
Study: 33965414

Group type: EXPERIMENTAL
Intervention: Pretarsal (PTS) BoNT‐A injection
Number of subjects: 24

Group type: COMPARATOR
Intervention: Preseptal (PST) BoNT‐A injection
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both PTS and PST BoNT‐A injections
Number of subjects: 24
Study: 32108437

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting liver metastasis in pancreatic cancer
Number of subjects: 604
Study: 35605520

Group type: EXPERIMENTAL
Intervention: Eustachian tube insufflation with thermal water
Number of subjects: 74
Study: 33238798

Group type: EXPERIMENTAL
Intervention: Myo-inositol (2g) plus folic acid (200µg)
Number of subjects: 223

Group type: COMPARATOR
Intervention: Placebo (200µg of folic acid)
Number of subjects: 223
Study: 33147205

Group type: EXPERIMENTAL
Intervention: Percutaneous reduction and hollow screw fixation (PRHCF)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Open reduction and internal fixation (ORIF)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: PRHCF
Number of subjects: 71
Study: 34541914

Group type: EXPERIMENTAL
Intervention: DL‐beta‐hydroxybutyrate
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 32778159

Group type: EXPERIMENTAL
Intervention: Blog-delivered healthy eating intervention
Number of subjects: 84

Group type: COMPARATOR
Intervention: Facebook recruitment method
Number of subjects: 84

Group type: COMPARATOR
Intervention: Traditional recruitment methods
Number of subjects: 84
Study: 34543256

Group type: EXPERIMENTAL
Intervention: NGAL/hepcidin-25 ratio
Number of subjects: 198
Study: 34949566

Group type: EXPERIMENTAL
Intervention: Retrieval Practice (RP) with anodal tDCS
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Retrieval Practice (RP) with sham stimulation
Number of subjects: 119

Group type: COMPARATOR
Intervention: Restudy with anodal tDCS
Number of subjects: 119

Group type: COMPARATOR
Intervention: Restudy with sham stimulation
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Retrieval Practice (RP)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Restudy
Number of subjects: 119
Study: 34506563

Group type: EXPERIMENTAL
Intervention: Novel formula for predicting cirrhosis based on ln type IV collagen 7S, ln hyaluronic acid, and ln WFA+‐Mac‐2 BP.
Number of subjects: 749

Group type: EXPERIMENTAL
Intervention: Novel formula scores
Number of subjects: 749

Group type: COMPARATOR
Intervention: Conventional fibrosis markers and indices
Number of subjects: 749
Study: 34082279

Group type: EXPERIMENTAL
Intervention: Single-session computerized anxiety sensitivity intervention
Number of subjects: 68

Group type: COMPARATOR
Intervention: Active control condition
Number of subjects: 68
Study: 34237041

Group type: EXPERIMENTAL
Intervention: Direct Anterior Approach (DAA)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Posterior Approach (PA)
Number of subjects: 75
Study: 32824387

Group type: EXPERIMENTAL
Intervention: K-diet
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 10
Study: 33247555

Group type: EXPERIMENTAL
Intervention: Cool Little Kids program
Number of subjects: 545

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 545
Study: 33380579

Group type: EXPERIMENTAL
Intervention: Intrathecal dexmedetomidine (5 μg) with 8 mg bupivacaine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Intrathecal sufentanil (2.5 μg) with 8 mg bupivacaine
Number of subjects: 80
Study: 34237810

Group type: EXPERIMENTAL
Intervention: Experimental biopsy group (MRI with targeted and standard biopsy)
Number of subjects: 1532

Group type: COMPARATOR
Intervention: Standard biopsy group
Number of subjects: 1532
Study: 32298418

Group type: EXPERIMENTAL
Intervention: Contact force-guided catheter ablation (CA)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Blinded to contact force (control group)
Number of subjects: 156
Study: 35389015

Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser with 1% terbinafine cream
Number of subjects: 100

Group type: COMPARATOR
Intervention: Itraconazole (one-week pulse therapy)
Number of subjects: 100
Study: 34245857

Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) > 3.33 mg/l
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-sensitivity CRP assay
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Perioperational CRP
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CRP-to-albumin ratio and Glasgow Prognostic Score (GPS)
Number of subjects: 0
Study: 33484158

Group type: EXPERIMENTAL
Intervention: Combined massage and warm compress to the perineum (MassComp)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Standard 'hands-off' care (Control)
Number of subjects: 156
Study: 34986394

Group type: EXPERIMENTAL
Intervention: Lower dose rNAPc2
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Higher dose rNAPc2
Number of subjects: 160

Group type: COMPARATOR
Intervention: Heparin (control)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: All groups (rNAPc2 and Heparin)
Number of subjects: 160
Study: 33556039

Group type: EXPERIMENTAL
Intervention: Improved latrine use
Number of subjects: 32172

Group type: COMPARATOR
Intervention: Unimproved latrine use
Number of subjects: 32172

Group type: COMPARATOR
Intervention: Open defecation
Number of subjects: 32172
Study: 32798588

Group type: COMPARATOR
Intervention: Rinsing (without toothbrushing)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (toothbrushing without toothpaste)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Brushing (toothbrushing with toothpaste)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Brushing + Rinsing
Number of subjects: 15

Group type: COMPARATOR
Intervention: Rinsing + Brushing
Number of subjects: 15
Study: 32000549

Group type: EXPERIMENTAL
Intervention: Platelet-Rich Fibrin (PRF) applied to the wound and covered with Vaseline gauze and wet dressing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (Vaseline petrolatum gauze) applied to the wound
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Platelet-Rich Fibrin (PRF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (Vaseline petrolatum gauze)
Number of subjects: 0
Study: 33694074

Group type: EXPERIMENTAL
Intervention: Encapsulated pupae
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Unprotected pupae
Number of subjects: 5

Group type: COMPARATOR
Intervention: Pupae released between soybean lines (V2 and V9)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Pupae released in reproductive stages (R1, R4, R7)
Number of subjects: 5
Study: 33152978

Group type: EXPERIMENTAL
Intervention: Weight
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Thyromental Distance (TMD)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Sternomental Distance (SMD)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Frontal Plane to Chin Distance by Weight ratio (FPCD/Wt ratio)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: FPCD/Wt ratio
Number of subjects: 100
Study: 35959348

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided PICC combined with predictive nursing
Number of subjects: 88
Study: 33601732

Group type: EXPERIMENTAL
Intervention: Computer-based Cognitive Behavioral Therapy (CCBT) with therapeutic support
Number of subjects: 50

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: High homework compliance in CCBT group
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Low homework compliance in CCBT group
Number of subjects: 50
Study: 35045969

Group type: EXPERIMENTAL
Intervention: Surgical fixation with K‐wires
Number of subjects: 500

Group type: COMPARATOR
Intervention: Moulded cast
Number of subjects: 500
Study: 33019861

Group type: EXPERIMENTAL
Intervention: GOALS training
Number of subjects: 40

Group type: COMPARATOR
Intervention: Brain-Health Education (BHE) training
Number of subjects: 40